Hepatitis C Pill Leads 27 US Drug Approvals in 2013
Hepatitis C pill leads 27 US drug approvals in 2013
WASHINGTON — Gilead Sciences Inc.'s hepatitis C pill Sovaldi led 27 new U.S. drug approvals in 2013, a “breakthrough” therapy being chased by competitors this year. Gilead's pill, designed to cut treatment time by about half, was approved under the …
Read more on West Hawaii Today
Text of the president's State of the Union speech
A rural doctor gave a young child the first prescription to treat asthma that his mother could afford. A man took the bus home from the graveyard shift, bone-tired but dreaming big dreams for his son. And in tight-knit communities across America …
Read more on Honolulu Star-Advertiser
Related Drug Treatment Centers Hawaii Information…